Among no‐cirrhotic patients, the average level of AFP in the HBeAg‐ group was significantly higher than that in the HBeAg+ group, suggesting we should be wary about the possibility to develop HCC among these CHB patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.